References

Cador C, Herve S, Andraud M Maternally-derived antibodies do not prevent transmission of swine influenza A virus between pigs. Vet. Res. 2016a; 47 https://doi.org/10.1186/s13567-016-0365-6

Cador C, Rose N, Willem L. Andraud, M. Maternally derived immunity extends swine influenza A virus persistence within farrow-to-finish pig farms: insights from a stochastic event-driven metapopulation model. PloS One. 2016b; 1

Deblanc C, Hervé S, Gorin S Maternally-derived antibodies do not inhibit swine influenza virus replication in piglets but decrease excreted virus infectivity and impair post-infectious immune responses. Veterinary microbiology. 2018; 216:142-52

Diehl JR, Day BN. Effect of prostaglandin F2α on luteal function in swine. J Anim Sci. 1974; 39:392-6

Grebe KM, Yewdell JW, Bennink JR. Heterosubtypic immunity to influenza A virus: Where do we stand?. Microbes Infect. 2008; 10:(9)1024-9 https://doi.org/10.1016/j.micinf.2008.07.002

Gumbert S, Froehlich S, Rieger A, Stadler J, Ritzmann M, Zoels S. Reproductive performance of pandemic influenza A virus infected sow herds before and after implementation of a vaccine against the influenza A (H1N1) pdm09 virus. Porcine Health Management. 2020; 6:(1)1-9

Henritzi D, Zhao N, Starick E Rapid detection and subtyping of European swine influenza viruses in porcine clinical samples by haemagglutinin-and neuraminidase-specific tetra-and triplex real-time RT-PCR s. Influenza and other respiratory viruses. Influenza Other Respir Viruses. 2016; 10:(6)504-17 https://doi.org/10.1111/irv.12407

Henritzi D. Epidemiology of swine influenza viruses in Europe: Surveillance of domestic pig populations in several European countries 2015-2017.: University of Hanover; 2019

Janke BH. Diagnosis of swine influenza. Swine Health Prod. 2000; 8:(2)79-84

H1N1 Influenza (Swine Flu). 2019. https://www.ncbi.nlm.nih.gov/books/NBK513241/

Kim JC, Kim HM, Kang YM, Ku KB, Park EH, Yum J. Severe pathogenesis of influenza B virus in pregnant mice. Virology. 2014; 448:74-81 https://doi.org/10.1016/j.virol.2013.10.001

Lee JH, Gramer MR, Joo HS. Efficacy of swine influenza A virus vaccines against an H3N2 virus variant. Can J Vet Res. 2007; 71:(3)207-12

Littauer EQ, Esser ES, Antao OQ, Vassilieva EV, Compans RW, Skountzou I. H1N1 influenza virus infection results in adverse pregnancy outcomes by disrupting tissue-specific hormonal regulation. PLoS Pathogens. 2017; 13:1-27 https://doi.org/10.1371/journal.ppat.1006757

Ma W, Richt JA. Swine influenza vaccines: Current status and future perspectives. Anim Health Res Rev. 2010; 11:(1)81-96 https://doi.org/10.1017/S146625231000006X

Ma W, Kahn RE, Richt JA. The pig as a mixing vessel for influenza viruses: human and veterinary implications. J Mol Genet Med. 2009; 3:(1)158-66

Pomorska-Mól M, Dors A, Kwit K, Kowalczyk A, Stasiak E, Pejsak Z. Kinetics of single and dual infection of pigs with swine influenza virus and Actino-bacillus pleuropneumoniae. Vet Microbiol. 2017; 201:113-20 https://doi.org/10.1016/j.vetmic.2017.01.011

Pomorska-Mól M, Dors A, Kwit K, Czyżewska-Dors E, Pejsak Z. Coinfection modulates inflammatory responses, clinical outcome and pathogen load of H1N1 swine influenza virus and Haemophilus parasuis infections in pigs. BMC Vet Res. 2017; 13 https://doi.org/10.1186/s12917-017-1298-7

Salmon H, Berri M, Gerdts V, Meurens F. Humoral and cellular factors of maternal immunity in swine. Dev Comp Immunol. 2009; 33:(3)384-93 https://doi.org/10.1016/j.dci.2008.07.007

Samji T. Influenza A: Understanding the viral life cycle. Yale J Biol Med. 2009; 82:153-9

Sandbulte MR, Spickler AR, Zaabel PK, Roth JA. Optimal use of vaccines for control of influenza A virus in swine. Vaccines. 2015; 3:(1)22-73 https://doi.org/10.3390/vaccines3010022

Sreta D, Kedkovid R, Tuamsang S, Kitikoon P, Thanawongnuwech R. Pathogenesis of swine influenza virus (Thai isolates) in weanling pigs: an experimental trial. Virol J. 2009; 6 https://doi.org/10.1186/1743-422X-6-34

Taylor DJ. Pig diseases (No. Edition 6). Dr. DJ Taylor, 31 North Birbiston Road. 1995;

Thacker EL, Thacker BJ, Janke BH. Interaction between Mycoplasma hyopneumoniae and swine influenza virus. J Clin Microbiol. 2001; 39:(7)2525-30

Torremorell M, Allerson M, Corzo C, Diaz A, Gramer M. Transmission of influenza A virus in pigs. Transbound Emerg Dis. 2012; 59:68-84 https://doi.org/10.1111/j.1865-1682.2011.01300.x

Van Reeth K, Nauwynck H, Pensaert M. Dual infections of feeder pigs with porcine reproductive and respiratory syndrome virus followed by porcine respiratory coronavirus or swine influenza virus: a clinical and virological study. Vet Microbiol. 1996; 48:(3-4)325-35

Vincent AL, Perez DR, Rajao D Influenza A virus vaccines for swine. Vet Microb. 2017; 206:35-44 https://doi.org/10.1016/j.vetmic.2016.11.026

Zhu H, Webby R, Lam TT, Smith DK, Peiris JS, Guan Y. History of swine influenza viruses in Asia. Curr Top Microbiol Immunol. 2013; 370:57-68 https://doi.org/10.1007/82_2011_179

The impact of swine influenza and how to control it on farm

02 March 2020
11 mins read
Volume 25 · Issue 2
Figure 1. The structure of influenza virus, including the surface proteins haemagglutinin (HA) and neuraminidase (NA), and the RNA genome.
Figure 1. The structure of influenza virus, including the surface proteins haemagglutinin (HA) and neuraminidase (NA), and the RNA genome.

Abstract

Swine influenza (SIV) can reduce productivity on farm and therefore can have a large economic impact also. The virus has four common lineages in swine, H1avN1av, H1huN2, H3N2 and H1pdmN1pdm (the pandemic strain). The virus invades the respiratory tract and therefore the majority of clinical signs are of respiratory nature, including sneezing, coughing and nasal discharge, which can also be accompanied by fever and lethargy. Diagnosis of the disease is important to determine the strain on the farm and therefore implement a control plan which may include biosecurity and hygiene measures in combination with vaccination. Vaccination has been shown to be effective in reducing the clinical signs, lung lesions and the viral shedding. Vaccination of the breeding herd can result in an improvement in reproductive performance, such as a reduction in the return to oestrus rate and an increase in the number of piglets born alive. Control of SIV should be a combined approach to achieve the best results on farm.

Swine influenza A virus (SIV) can have a large economic impact on the pig industry, and the zoonotic threat also makes it a concern for public health. A study has shown that 56% of UK farms were positive for influenza, based on 146 samples from nine farms. The same study also showed Ireland to have a number of positive farms for pandemic SIV, H1pdmN1pdm (Henritzi, 2019). Biosecurity and hygiene protocols should be implemented on farm to reduce environmental contamination and therefore the risk of pathogen spread. Understanding of diagnostic testing is extremely important in implementing the correct vaccination protocol on farm and the various methods of testing and the vaccination options will be discussed in this article.

Swine influenza is caused by influenza A virus which is an orthomyxovirus 80–120 nm in diameter, comprising eight pieces of segmented RNA coding for 12 proteins, including haemagglutinin (HA), neuraminidase (NA) and matrix 2 proteins which form part of the virus envelope (Figure 1). The virus is classified by type A, B, C or D, which is based on the matrix and the nucleoprotein. The subtypes are then defined by the haemagglutinin (HA) and neuraminidase (NA) proteins (Sandbulte et al, 2015). New subtypes can develop by antigenic shift, antigenic drift or reassortment. Three reassortment porcine lineages circulate in swine in Europe, including H1avN1av, H1huN2 and H3N2. However, the human pandemic H1N1/2009 virus has established a fourth lineage in swine, H1pdmN1pdm (Henritzi et al, 2016).

Register now to continue reading

Thank you for visiting UK-VET Companion Animal and reading some of our peer-reviewed content for veterinary professionals. To continue reading this article, please register today.